FDA NDC Directory · JSON-LD · Markdown

Nintedanib

NDC 69097-641 · HUMAN PRESCRIPTION DRUG · CAPSULE

Labeler / ManufacturerCipla USA Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA212609
Dosage form / routeCAPSULE · ORAL
Active ingredientsNINTEDANIB ESYLATE (100 mg/1)
Marketing started20260402
Package count1

External sources

Source: openFDA. Public-domain (CC0).